APA (7th ed.) Citation

He, N., Li, G., Liu, J., Liu, W., Tian, R., & Ma, D. COVID-19 mitigates the response to TKIs in patients with CML via the inhibition of T-cell immunity. Frontiers Media S.A.

Chicago Style (17th ed.) Citation

He, Na, Guosheng Li, Jinting Liu, Wancheng Liu, Ruifeng Tian, and Daoxin Ma. COVID-19 Mitigates the Response to TKIs in Patients with CML via the Inhibition of T-cell Immunity. Frontiers Media S.A.

MLA (9th ed.) Citation

He, Na, et al. COVID-19 Mitigates the Response to TKIs in Patients with CML via the Inhibition of T-cell Immunity. Frontiers Media S.A.